THE Pharmaceutical Society of Australia (PSA) has released its 2023/24 annual report, celebrating key advancements for the organisation and the whole pharmacy profession.
Among its achievements, PSA secured the first-ever Strategic Agreement on Professional Pharmacist Practice with the Australian Government, reinforcing the critical role of pharmacists in healthcare and expanding their scope of practice.
The PSA emphasised medicines safety with updated Professional Practice Standards and the release of APF26, the latest Australian Pharmaceutical Formulary edition.
These tools, combined with targeted training, support community pharmacists in meeting new demands.
PSA also advocated for state and federal reforms to broaden pharmacists' roles, initiating pilot programs like Queensland's Scope of Practice Pilot and enabling pharmacists to manage urinary tract infections, provide vaccinations, and support chronic disease management.
Reflecting on the past year, PSA National President A/Prof Fei Sim and CEO Steve Morris affirmed the organisation's commitment to its members, stating their focus remains firmly on providing professional resources at every stage of a pharmacist's career as needed to "not just survive but thrive". JG
To read the report, CLICK HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 08 Nov 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Nov 24
